Multivariate cox proportional hazards model assessing the risk for primary outcome (Ischemic stroke, TIA, MI, or Death) with respect to the CYP2C19 polymorphism and use of clopidogrel or aspirin. The gene discussed is CYP2C19; the disease is transient ischemic attack.